Clinical Trials at Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
As of August 2026, 38 paid clinical trials are recruiting at Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), located at Memorial Sloan Kettering Commack Nonna’s Garden Foundation Cancer Center, 650 Commack Rd, Commack, NY 11725, phone (631) 636-0590 in Commack, New York. Active studies at this site cover conditions such as Breast Cancer, Multiple Myeloma and Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
38 clinical trials at Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
·Clear filters·A Study of Mirdametinib in People With Central Nervous System Tumors
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
A Registry for People With Lung Cancer
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
A Study of 177Lu-PSMA-617 in People With Gliomas
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
Study of Aerobic Training for People Receiving Treatment for Breast Cancer
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
A Study of Tarlatamab for People With Prostate Cancer
A Study of CRD3874-SI in People With Solid Tumors
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
A Study of Multiparametric Ultrasound Imaging Methods
A Study of Blood Pressure Control During Cancer Treatment
A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
A Study of Stereotactic Radiosurgery (SRS) to Treat Pain in the Chest and/or Stomach Wall
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
A Study of Sotorasib in People With Non-Small Cell Lung Cancer
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Common conditions studied in Commack
- Breast Cancer (28 active studies)
- Multiple Myeloma (14 active studies)
- Prostate Cancer (12 active studies)
- Acute Myeloid Leukemia (11 active studies)
- Endometrial Cancer (10 active studies)
- Non-Small Cell Lung Cancer (9 active studies)
Leading research sponsors in Commack
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Pfizer
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Commack?
There are approximately 322 recruiting clinical trials in Commack, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Commack pay participants?
Most recruiting trials in Commack compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Commack?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Commack?
The most common conditions under active study in Commack include Breast Cancer (28), Multiple Myeloma (14), Prostate Cancer (12), Acute Myeloid Leukemia (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Commack?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Commack on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Commack?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Commack?
Recruiting research sites in Commack include Memorial Sloan Kettering Commack, Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Commack right now?
The largest active categories in Commack are Cancer & tumors (254), Neurology & pain (9), Pediatric (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)?
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) is located at Memorial Sloan Kettering Commack Nonna’s Garden Foundation Cancer Center, 650 Commack Rd, Commack, NY 11725. Use the Google Maps link in the intro above to get directions.
How do I contact Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)?
You can reach Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) by phone at (631) 636-0590. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.